Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.08.26.672349

Dynamic neural states underpin bradykinesia severity in Parkinsons disease

Abstract

BackgroundBradykinesia in Parkinsons disease (PD) may arise due to transient, network-wide neural dynamics that extend beyond beta-band oscillatory activity within the motor cortical-subthalamic nucleus (STN) circuit. MethodsWe address this question by using Hidden Markov Models (HMMs) to identify neural states from chronic motor cortical and STN recordings in five PD patients (1,046 hours from 10 hemispheres), with concurrent measurements of bradykinesia using wearable sensors. FindingsWe identified four neural states with distinct spectral and temporal features. Two states exhibited spectral signatures--particularly STN low and high gamma, STN delta/alpha, cortical beta, and cortico-STN beta coherence--that predicted worsening bradykinesia. However, STN beta power alone was not consistently predictive, challenging traditional beta-centric views. These states also displayed compensatory features associated with bradykinesia amelioration, including cortical delta/alpha activity, cortical high gamma, and cortico-STN high gamma coherence. Two additional states affected bradykinesia through temporal rather than spectral properties. Prolonged lifetimes of one of these state worsened symptoms, whereas increased occurrences of another, marked by local beta without cortico-STN beta coherence, improved motor function. InterpretationOur findings highlight the multidimensional nature of bradykinesia and suggest that state-aware, adaptive interventions targeting state features--rather than single frequency bands--may offer new opportunities for improved deep brain stimulation in PD. FundingAO is supported by an MRC Clinician Scientist Fellowship (MR/W024810/1) and a Rosetrees Trust/Race Against Dementia Team award. BA and AO acknowledge funding support from the Oxford University Hospitals Charity and Jon Moulton Trust. TL acknowledges funding support from the China Scholarship Council. Research in ContextO_ST_ABSEvidence before this studyC_ST_ABSPrevious work has demonstrated that subthalamic nucleus oscillatory activity at beta (15-30 Hz) frequencies correlates positively with motor symptoms in Parkinsons disease. This has led to beta activity being used as a biomarker for adaptive Deep Brain Stimulation. It remains unclear however whether other oscillatory features within the broader motor cortical-subthalamic nucleus network could provide improved biomarkers for tracking symptom severity. Added value of this studyWe address this by performing chronic motor cortical and subthalamic nucleus recordings in Parkinsons disease patients during activities of daily living. Simultaneous measurements of symptom severity were captured using wearable sensors. We used Hidden Markov Models to identify transient states of neural activity and related these to symptom severity. Although cortical beta and cortico-STN beta coherence predicted worsening motor symptoms, STN beta activity alone was not a consistent predictor. Interestingly, we identified spectral features associated with motor symptom improvements, including cortical delta/alpha activity, cortical high gamma, and cortico-STN high gamma coherence. Additionally, there was a compensatory state characterised by short-lived cortical and subthalamic nucleus beta activity, whose increased occurrence was associated with symptomatic improvements. Implications of all the available evidenceOur findings highlight the importance of prolonged, high temporal resolution measurements of both neural activity and symptom severity for discovering adaptive Deep Brain Stimulation biomarkers. Crucially, we identify new target states and spectral features for improving motor symptoms in Parkinsons disease.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sharma, A., Sargezeh, B. A., Hahn, A., Shcherbakova, M., Neumann, W. J., Little, S., Starr, P., Oswal, A.. 2025-08-31. Dynamic neural states underpin bradykinesia severity in Parkinsons disease. https://doi.org/10.1101/2025.08.26.672349

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Different hippocampal subfield volumes predict source memory performance and general cognitive ability in an adult lifespan sample

Modest positive associations between episodic memory performance and whole hippocampal and hippocampal subfield volumes have been reported in numerous prior studies. A smaller number of studies have reported associations between hippocampal volume and performance on tests of non-mnemonic cognition. The present study examined whether these associations were evident in a lifespan sample of cognitively healthy adults. Of particular interest was whether any identified associations were sensitive to age, and whether associations between subfield volumes and mnemonic and non-mnemonic performance were subfield dependent. We acquired high-resolution T1- and T2-weighted structural images from 163 adults (18-87 years of age). Participants also undertook a comprehensive neuropsychological test battery and an in-scanner test of source memory. Principal components analysis was employed to reduce the neuropsychological test scores to 5 cognitive components. Two components reflected memory performance while the other three reflected different aspects of non-mnemonic cognition. Hippocampal subfields (Cornu Ammonis (CA)1, CA2-3, dentate gyrus (DG) and subiculum) were segmented and measured with the Automated Segmentation of Hippocampus Subfields (ASHS) package. Source memory performance was selectively associated across participants with CA2-3 volume. By contrast, both mnemonic and non-mnemonic component scores derived from the test battery were associated exclusively with the volume of the DG. All associations were age-invariant. The findings indicate that different cognitive domains can be dissociated by virtue of their associations with different hippocampal subfields. Of importance, these associations appear to be life-long and hence are unlikely to reflect individual differences in age-related decline in structural integrity.

neuroscience↗

Cell type specific astrocytic feedback regulates excitation inhibition balance and cortical network dynamics

Astrocytes actively regulate synaptic transmission and neuronal excitability, yet their role in orchestrating macroscopic cortical network regimes and slow-wave oscillations remains an active area of reasearch. This study investigates how bidirectional neuron astrocyte interactions shape emergent population dynamics using a computational network model of excitatory and inhibitory neurons coupled to an astrocyte. The results identify astrocytic feedback topology, rather than astrocytic coupling strength alone, as a key determinant of emergent cortical network dynamics. By systematically dissecting pathway-specific connectivity, it has been shown that the neuronal population driving astrocytic activation and the neuronal population receiving gliotransmission jointly determine whether the network occupies asynchronous irregular (AI), synchronous irregular (SI), synchronous regular(SR), asynchronous regular(AR) or quiescent regimes.Directing gliotransmission selectively onto excitatory neurons consistently promotes population synchrony regardless of the population influencing astrocytic dynamics, whereas selective modulation of inhibitory interneurons induces network quiescence via strong suppression. Under dual-target gliotransmission, network synchrony is dictated by the population driving astrocytic dynamics: excitatory-only drive promotes synchrony, while combined or inhibitory-specific drive preserves asynchronous states. Furthermore, the model reveals that astrocytic signaling kinetics provide an additional temporal control mechanism that regulates the frequency and persistence of self sustained up states.

neuroscience↗

VCP inhibition prevents cone photoreceptor degeneration in the cpfl1 mouse model of achromatopsia

Achromatopsia (ACHM) is a rare autosomal recessive retinal disorder characterized by absent cone photoreceptor function from early life, leading to severe visual impairment. Mutations in genes involved in the cone phototransduction cascade frequently result in elevated cyclic guanosine monophosphate (cGMP) levels and activation of stress pathways, including endoplasmic reticulum (ER) stress and the unfolded protein response. Targeting common downstream mechanisms rather than individual mutations may provide a broadly applicable therapeutic strategy. Here, we investigated whether pharmacological inhibition of valosin-containing protein (VCP), a key regulator of ER and protein homeostasis, can prevent cone degeneration in the spontaneous cone photoreceptor function loss 1 (cpfl1) mouse model of ACHM. Organotypic culture of retinal explants from cpfl1 mice were treated with the selective VCP inhibitor ML240. Cone survival, cell death, opsin expression and localization were assessed by TUNEL assay, immunohistochemistry, and quantitative image analysis. ML240 treatment significantly increased cone density and improved cone opsin expression and trafficking to the outer segments (OSs) in cpfl1 explants compared to controls. Importantly, rhodopsin trafficking in rod photoreceptors was unaffected, indicating that VCP inhibition did not impair normal rod phototransduction. These findings demonstrate that VCP inhibition by ML240 effectively preserves cone photoreceptors and improves cone-specific functional markers in the cpfl1 model. Targeting VCP may represent a mutation-independent therapeutic strategy for preventing cone death in ACHM.

neuroscience↗